Colorectal cancer statistics, 2014
2014/03/01 by Rebecca L. Siegel, Rebecca Siegel, Carol DeSantis +1 · 30 citations
Medicine · #Colorectal Cancer Screening and Detection #Genetic factors in colorectal cancer #Colorectal Cancer Surgical Treatments
paper · doi:10.3322/caac.21220
Abstract
Colorectal cancer is the third most common cancer and the third leading cause of cancer death in men and women in the United States. This article provides an overview of colorectal cancer statistics, including the most current data on incidence, survival, and mortality rates and trends. Incidence data were provided by the National Cancer Institute's Surveillance, Epidemiology, and End Results program and the North American Association of Central Cancer Registries. Mortality data were provided by the National Center for Health Statistics. In 2014, an estimated 71,830 men and 65,000 women will be diagnosed with colorectal cancer and 26,270 men and 24,040 women will die of the disease. Greater than one-third of all deaths (29% in men and 43% in women) will occur in individuals aged 80 years and older. There is substantial variation in tumor location by age. For example, 26% of colorectal cancers in women aged younger than 50 years occur in the proximal colon, compared with 56% of cases in women aged 80 years and older. Incidence and death rates are highest in blacks and lowest in Asians/Pacific Islanders; among males during 2006 through 2010, death rates in blacks (29.4 per 100,000 population) were more than double those in Asians/Pacific Islanders (13.1) and 50% higher than those in non-Hispanic whites (19.2). Overall, incidence rates decreased by approximately 3% per year during the past decade (2001-2010). Notably, the largest drops occurred in adults aged 65 and older. For instance, rates for tumors located in the distal colon decreased by more than 5% per year. In contrast, rates increased during this time period among adults younger than 50 years. Colorectal cancer death rates declined by approximately 2% per year during the 1990s and by approximately 3% per year during the past decade. Progress in reducing colorectal cancer death rates can be accelerated by improving access to and use of screening and standard treatment in all populations.
Citations
Cited by
- Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females
- Colorectal cancer screening: a global overview of existing programmes
- <i>Fusobacterium</i>’s link to colorectal neoplasia sequenced: A systematic review and future insights
- PARP inhibitor BMN673 triggers PARylation-mediated ATF4-GDF15 pathway to drive autophagy and ferroptosis in ataxia telangiectasia mutated gene-deficient colorectal cancer cells
- Detecting, Localising and Classifying Polyps from Colonoscopy Videos using Deep Learning
- Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. [europepmc]
- Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. [europepmc]
- American Cancer Society Colorectal Cancer Survivorship Care Guidelines. [europepmc]
- Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females. [europepmc]
- Organoid Models of Human Gastrointestinal Development and Disease. [europepmc]
- Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. [europepmc]
- Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. [europepmc]
- Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy. [europepmc]
- Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. [europepmc]
- Differentiation of Human Pluripotent Stem Cells into Colonic Organoids via Transient Activation of BMP Signaling. [europepmc]
- Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development. [europepmc]
- NCCN Guidelines Insights: Colon Cancer, Version 2.2018. [europepmc]
- The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. [europepmc]
- Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome. [europepmc]
- Immunotherapy in colorectal cancer: rationale, challenges and potential. [europepmc]
- Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. [europepmc]
- YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma. [europepmc]
- Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies. [europepmc]
- Exercise as a prescription for patients with various diseases. [europepmc]
- The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. [europepmc]
- Immunotherapy, Inflammation and Colorectal Cancer. [europepmc]
- Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis. [europepmc]
- Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer. [europepmc]
- Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now? [europepmc]
- Biomarkers in Cancer Detection, Diagnosis, and Prognosis. [europepmc]
Related